Breast

  • NO PAIN

  • NO RADIATION

  • EARLY DETECTION

  • NO COMPRESSION

  • REPORT COMPLETED BY MD

  • FDA CLEARED AS AN ADJUNCTIVE BREAST CANCER SCREENING

Thermography detects the subtle physiologic (functional) changes that accompany breast pathology, whether it is cancer, fibrocystic disease, an infection, or a vascular disease.  Your doctor can then plan accordingly and lay out a careful program to further diagnose and/or monitor you during and after treatment.

 

Similar to other forms of breast testing, a stable baseline needs to be established to ensure that your thermal patterns remain unchanged.  All of your thermograms are kept on record and once your stable thermal pattern has been established any changes can be detected during your routine annual studies.  

Who can benefit?
  • All Women

  • Fibrocystic

  • Dense Breasts

  • Implants 

  • Mastectomy

  • Reconstruction

  • Young Women

  • and more... 

ALL WOMEN can benefit from thermography.  It can be especially appropriate for younger women whose denser breast tissue can make it more difficult for mammography to be effective.  Also for women of all ages who, for many reasons, are unable to undergo routine mammography.  

 

It takes years for a tumor to grow thus the earliest possible indication of abnormality is needed to allow for the earliest possible treatment and intervention.  

Breast thermography's ability to detect a pre-cancerous state of the breast, or signs of cancer at an extremely early stage, lies in its unique capability of monitoring the temperature variations and blood vessels alterations produced by the earliest changes in tissue physiology.

© 2019 by Mobile Thermographic Imaging. All rights reserved.

Disclaimer: Breast thermography is not a replacement or alternative for mammography or any other form of breast imaging. Breast thermography is meant to be used in addition to mammography and other tests. Breast thermography and mammography are complementary procedures, one does not replace the other. All thermography reports are meant to identify thermal emissions that suggest potential risk markers only and do not in any way suggest diagnosis and/or treatment. No breast screening is 100% accurate. The information provided in or through this website is not intended to be a substitute for professional medical advice, diagnosis or treatment provided by your own Medical Provider. Mobile Thermographic Imaging has no liability to any person or entity for any adverse consequence alleged to have happened directly or indirectly as a consequence of this material. The information provided in or through this website is for educational and informational purposes only. Telethermography systems are FDA regulated as a medical device under 21 CFR 884.2980. Telethermographic systems are intended as an adjunctive diagnostic screening

  • b-facebook